KOL Perspectives: Mid-to-Late Stage Pipeline Therapies in Lupus

Market: Pharmaceuticals and Healthcare

Global, 39 pages report, published by GlobalData

Report ThumbnailFebruary-2018
KOL Perspectives: Mid-to-Late Stage Pipeline Therapies in Lupus

Summary

This KOL Insight briefing focuses on opinions of mid- to late-stage pipeline therapies in lupus.

The briefing includes analysis of KOL opinion on the following topic areas -
- Development of Lupuzor for SLE
- Lupuzor’s Phase III trial design
- Lupuzor’s Phase IIb efficacy data in SLE
- Anticipated future use of Lupuzor in SLE
- Development of baricitinib in SLE
- Endpoints used in baricitinib’s Phase II trial
- Expectati

Read More
  • Table of Contents
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataKOL Perspectives: Mid-to-Late Stage Pipeline Therapies in LupusProduct ThumbnailKOL Perspectives: Mid-to-Late Stage Pipeline Therapies in Lupus, Industry ReportProduct #: 1190966
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved